FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine and pharmaceutics and represents a method for preventing reperfusion syndrome in acute myocardial infarction, involving intravenous introduction of lithium chloride on the model of reperfusion injury in myocardial ischemia, differs from known methods in that lithium chloride solution is introduced in dose of 30 mg/kg at the beginning of cardiac reperfusion.
EFFECT: technical result consists in reducing the area of the left ventricular myocardial infarction area in its ischemically-reperfusion injury of coronary genesis by intravenous administration of LiCl solution at the beginning of reperfusion.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PHOSPHOLIPID EMULSION CONTAINING EFFECTIVE AMOUNT OF DIHYDROQUERCETIN FOR TREATING ISCHEMIA-REPERFUSION SYNDROME IN PATIENTS WITH ISCHEMIC ORGAN AND EXTREMITY INJURIES | 2021 |
|
RU2766681C1 |
| METHOD FOR APPLYING REPERFUSION THERAPY TO ACUTE MYOCARDIAL INFARCTION PATIENTS | 2002 |
|
RU2226097C2 |
| AGENT SIMULATING CARDIAC POSTCONDITIONING PHENOMENON | 2012 |
|
RU2502508C1 |
| METHOD OF TREATMENT OF ACUTE MYOCARDIAL INFARCTION | 2006 |
|
RU2343921C2 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| METHOD FOR REDUCING THE SIZE OF ISCHEMIC-REPERFUSION MYOCARDIAL INJURY WITH THE USE OF QUINACRINE | 2019 |
|
RU2716596C1 |
| IMPROVING THE RECOVERY FUNCTION OF THE CARDIOVASCULAR SYSTEM IN ISCHEMIA TETRADECAPEPTIDES | 2017 |
|
RU2648846C1 |
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
| METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
| WATER-SOLUBLE COMPOSITION, POSSESSIVE PROPERTIES OF CARDIO-PROTECTOR | 2010 |
|
RU2438698C1 |
